Bone marrow immune cells and drug resistance in acute myeloid leukemia

被引：0
|
作者：
Zhang, Miao [1 ,2 ]
Yang, You [1 ,2 ]
Liu, Jing [1 ,2 ]
Guo, Ling [1 ,2 ]
Guo, Qulian [1 ,2 ]
Liu, Wenjun [1 ,2 ]
机构：
[1] Southwest Med Univ, Affiliated Hosp, Dept Pediat Hematol Oncol, Children Hematol Oncol & Birth Defects Lab, Luzhou, Sichuan, Peoples R China
[2] Southwest Med Univ, Sichuan Clin Res Ctr Birth Defects, Affiliated Hosp, Luzhou, Sichuan, Peoples R China
来源：
EXPERIMENTAL BIOLOGY AND MEDICINE | 2025年 / 250卷
关键词：
leukemia; immune cells; drug resistance; bone marrow; immunosuppressive microenvironment; REGULATORY T-CELLS; SUPPRESSOR-CELLS; DENDRITIC CELLS; POOR-PROGNOSIS; NK CELLS; AML CELLS; IN-VITRO; EXPRESSION; ACTIVATION; INDUCTION;
D O I：
10.3389/ebm.2025.10235
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
In recent years, the relationship between the immunosuppressive niche of the bone marrow and therapy resistance in acute myeloid leukemia (AML) has become a research focus. The abnormal number and function of immunosuppressive cells, including regulatory T cells (Tregs) and myeloid-derived suppressor cells (MDSCs), along with the dysfunction and exhaustion of immunological effector cells, including cytotoxic T lymphocytes (CTLs), dendritic cells (DCs) and natural killer cells (NKs), can induce immune escape of leukemia cells and are closely linked to therapy resistance in leukemia. This article reviews the research progress on the relationship between immune cells in the marrow microenvironment and chemoresistance in AML, aiming to provide new ideas for the immunotherapy of AML.
引用
收藏
页数：17
相关论文
共 50 条
  • [41] Bone marrow niche-mediated survival of leukemia stem cells in acute myeloid leukemia: Yin and Yang
    Zhou, Hong-Sheng
    Carter, Bing Z.
    Andreeff, Michael
    CANCER BIOLOGY & MEDICINE, 2016, 13 (02) : 248 - 259
  • [42] Immune profiles in acute myeloid leukemia bone marrow associate with patient age, T-cell receptor clonality, and survival
    Bruck, Oscar
    Dufva, Olli
    Hohtari, Helena
    Blom, Sami
    Turkki, Riku
    Ilander, Mette
    Kovanen, Panu
    Pallaud, Celine
    Ramos, Pedro Marques
    Lahteenmaki, Hanna
    Valimaki, Katja
    El Missiry, Mohamed
    Ribeiro, Antonio
    Kallioniemi, Olli
    Porkka, Kimmo
    Pellinen, Teijo
    Mustjoki, Satu
    BLOOD ADVANCES, 2020, 4 (02) : 274 - 286
  • [43] Influence of Human Bone Marrow Mesenchymal Stem Cells Secretome from Acute Myeloid Leukemia Patients on the Proliferation and Death of K562 and K562-Lucena Leukemia Cell Lineages
    de Freitas, Fabio Alessandro
    Levy, Debora
    Reichert, Cadiele Oliana
    Sampaio-Silva, Juliana
    Giglio, Pedro Nogueira
    de Padua Covas Lage, Luis Alberto
    Demange, Marco Kawamura
    Pereira, Juliana
    Bydlowski, Sergio Paulo
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (09)
  • [44] Therapeutic resistance in acute myeloid leukemia cells is mediated by a novel ATM/mTOR pathway regulating oxidative phosphorylation
    Park, Hae J.
    Gregory, Mark A.
    Zaberezhnyy, Vadym
    Goodspeed, Andrew
    Jordan, Craig T.
    Kieft, Jeffrey S.
    DeGregori, James
    ELIFE, 2022, 11
  • [45] Reversible suppression of T cell function in the bone marrow microenvironment of acute myeloid leukemia
    Lamble, Adam J.
    Kosaka, Yoko
    Laderas, Ted
    Maffit, Allie
    Kaempf, Andy
    Brady, Lauren K.
    Wang, Weiwei
    Long, Nicola
    Saultz, Jennifer N.
    Mori, Motomi
    Soong, David
    LeFave, Clare V.
    Huang, Fei
    Adams, Homer, III
    Loriaux, Marc M.
    Tognon, Cristina E.
    Lo, Pierrette
    Tyner, Jeffrey W.
    Fan, Guang
    McWeeney, Shannon K.
    Druker, Brian J.
    Lind, Evan F.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2020, 117 (25) : 14331 - 14341
  • [46] Deregulation of Mitochondrial ATPsyn-β in Acute Myeloid Leukemia Cells and with Increased Drug Resistance
    Xiao, Xiang
    Yang, Jingke
    Li, Ruijuan
    Liu, Sufang
    Xu, Yunxiao
    Zheng, Wenli
    Yi, Yan
    Luo, Yunya
    Gong, Fanjie
    Peng, Honglin
    Pei, Minfei
    Deng, Mingyang
    Zhang, Guangsen
    PLOS ONE, 2013, 8 (12):
  • [47] Moving Myeloid Leukemia Drug Discovery Into the Third Dimension
    Wolf, Donna M. Cartledge
    Langhans, Sigrid A.
    FRONTIERS IN PEDIATRICS, 2019, 7
  • [48] Distinct protein signatures of acute myeloid leukemia bone marrow-derived stromal cells are prognostic for patient survival
    Kornblau, Steven M.
    Ruvolo, Peter P.
    Wang, Rui-Yu
    Battula, V. Lokesh
    Shpall, Elizabeth J.
    Ruvolo, Vivian R.
    McQueen, Teresa
    Qui, YiHua
    Zeng, Zhihong
    Pierce, Sherry
    Jacamo, Rodrigo
    Yoo, Suk-Young
    Le, Phuong M.
    Sun, Jeffrey
    Hail, Numsen, Jr.
    Konopleva, Marina
    Andreeff, Michael
    HAEMATOLOGICA, 2018, 103 (05) : 810 - 821
  • [49] Mesenchymal stromal cells derived from acute myeloid leukemia bone marrow exhibit aberrant cytogenetics and cytokine elaboration
    Huang, J. C.
    Basu, S. K.
    Zhao, X.
    Chien, S.
    Fang, M.
    Oehler, V. G.
    Appelbaum, F. R.
    Becker, P. S.
    BLOOD CANCER JOURNAL, 2015, 5 : e302 - e302
  • [50] Dependence of Acute Myeloid Leukemia on Adhesion within the Bone Marrow Microenvironment
    Becker, Pamela S.
    SCIENTIFIC WORLD JOURNAL, 2012,
12345